Skip to main content
Premium Trial:

Request an Annual Quote

PositiveID 2015 Revenues Balloon on License Fee, Recent Acquisitions

NEW YORK (GenomeWeb) – Biological detection systems firm PositiveID today reported a greater than 200 percent jump in revenues for 2015, primarily due to the receipt of a previously deferred licensee fee. However, the company still fell short of its own guidance.

For the 12-month period ended Dec. 31, PositiveID's revenues ballooned to $2.9 million from $945,000 in 2014.

Approximately 90 percent of revenues for the year came from the license fee paid by Boeing, which agreed in late 2012 to pay $2.5 million for the exclusive rights to PositiveID's M-BAND airborne bio-threat detector in North America. The remainder of the company's revenues for 2015 were derived from the operations of laboratory and communication vehicle maker ENG Mobile Systems and non-contact thermometer developer Thermomedics, both of which PositiveID acquired in 2015.

Despite the increase, however, the yearly revenues did not reach the level the company had expected — in early 2015, PositiveID predicted 2015 revenues to be in the range of $3 million to $6 million.

The firm's net loss for 2015 widened to $11.4 million from $7.2 million the year before. However, net loss per share narrowed to $.04 from $.09 in 2014 due to an increase in average shares outstanding.

Research and development spending rose to $1.4 million from $588,000, largely due to expenses around the development of the company's PCR-based point-of-care pathogen-detection system, Firefly Dx. PositiveID said it is currently seeking a partner to fund the additional development of Firefly Dx needed to prepare for commercialization. SG&A spending rose 30 percent to $5.6 million in 0215 from $4.3 million in 2014, attributable to overhead related to increased R&D and marketing expenses. 

At the end of 2015, PositiveID had cash totaling $173,000. 

Looking ahead, the firm reaffirmed its guidance for 2016 revenues of $5 million to $6 million.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.